Related Experiment Videos
Development of pediatric vaccine recommendations and policies
Larry K Pickering1, Walter A Orenstein
1National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. LPickering@cdc.gov
Insights
Childhood immunizations significantly reduced vaccine-preventable diseases. The complex vaccine development, approval, and implementation process involves rigorous safety and efficacy evaluations, followed by ongoing supply and financing considerations.
Area of Science:
- Pediatric medicine
- Immunology
- Public health policy
Background:
- Vaccine-preventable diseases have drastically declined following the introduction of immunizations.
- The recommended childhood immunization schedule is a cornerstone of public health.
- The journey of a vaccine from concept to widespread use is intricate.
Purpose of the Study:
- To review the complex process of vaccine development, approval, and implementation.
- To highlight the continuous evaluation of vaccine safety, immunogenicity, and efficacy.
- To examine post-approval challenges including supply, safety, effectiveness, and financing.
Main Methods:
- Review of vaccine development and regulatory pathways.
- Analysis of data evaluation at multiple stages: advisory committees, government agencies, and professional organizations.
- Examination of logistical factors in pediatric vaccine policy implementation.
Main Results:
- Vaccine introduction has led to significant reductions in targeted diseases.
- Rigorous, continuous evaluation of safety, immunogenicity, and efficacy data occurs throughout the process.
- Post-approval challenges related to supply, safety, effectiveness, and financing persist.
Conclusions:
- The vaccine approval and implementation process is complex and multi-staged.
- Ongoing monitoring and management are crucial for maintaining vaccine program success.
- Pediatric vaccine policy requires careful logistical consideration for effective delivery.
Abstract:
A significant decrease in each vaccine-preventable disease has occurred since the introduction of the respective immunizations now included in the recommended childhood immunization schedule. The process through which a vaccine must travel from development to approval and implementation is complex. Hurdles include receiving approval from several advisory committees, government agencies, and professional organizations. At each step in the process, data regarding safety, immunogenicity, and efficacy are evaluated continuously and rigorously. Once a vaccine is approved by the Food and Drug Administration (FDA) and incorporated into the recommended childhood immunization schedule, continuing issues include those that deal with supply, safety, effectiveness, and financing. The logistics of development and implementation of pediatric vaccine recommendations and policies are reviewed.